Back to Atlas
CTransientStandard research/education caution
CMP-0740
Research chemical/reference listing
CMX-2043
General biohacking / research
Bioactive effect candidate for Atlas review
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Bioactive compound
- Primary mechanism
- Mechanism requires verification
- Primary market use
- General biohacking / research
Pharmacology
- Molecular weight (Da)
- 406.52
- Oral bioavailability
- Route-dependent / verify
- Half-life
- ~1–12 h provisional PK estimate
- Route tags
- SubQ; Injectable; route-dependent
- Evidence level
- MCE product listing / research chemical signal
- Clinical status
- Research chemical/reference listing
- Value-for-money score
- 5 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
CMX-2043 is a novel analogue of α-Lipoic Acid ( HY-N0492 ). CMX-2043 is effective in antioxidant effect, activation of insulin receptor kinase , soluble tyrosine kinase , and Akt phosphorylation. CMX-2043 shows protection against ischemia-reperfusion injury (IRI) in rat model.